Form 4: Sarepta Therapeutics Director Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Kathryn Jean Boor, a director at Sarepta Therapeutics, sold 761 shares of common stock on March 11, 2024, to cover tax obligations arising from the vesting of restricted stock units.
Summary
- On March 11, 2024, Kathryn Jean Boor, a director of Sarepta Therapeutics, sold 761 shares of the company's common stock.
- The sale was executed at a price of $122.93 per share.
- The purpose of the sale was to generate cash for the payment of taxes due as a result of the vesting of certain restricted stock unit awards.
- Following the transaction, Ms. Boor directly owns 7,516 shares of Sarepta Therapeutics common stock.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes) by a company director. It doesn't indicate any positive or negative sentiment towards the company's prospects.
Industry Context
Sales of shares by company directors are a common occurrence, often related to compensation and tax planning. The sale itself is unlikely to have a significant impact on the company's overall performance or stock price, but it is important to monitor insider transactions for potential trends or signals.
Key Dates
| Date | Description |
|---|---|
| 03/11/2024 | Date of the transaction: Kathryn Jean Boor sold 761 shares of Sarepta Therapeutics common stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.